Gross Profit - Kilitch Drugs (India) Ltd (NSE:KILITCH) - Alpha Spread
K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 335.1 INR -0.76% Market Closed
Market Cap: 5.4B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Gross Profit Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Gross Profit
â‚ą557.8m
CAGR 3-Years
21%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Gross Profit
â‚ą205B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Gross Profit
â‚ą173.6B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Gross Profit
â‚ą386.3B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
10%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Gross Profit
â‚ą144.8B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Gross Profit
â‚ą82.7B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
10%

See Also

What is Kilitch Drugs (India) Ltd's Gross Profit?
Gross Profit
557.8m INR

Based on the financial report for Jun 30, 2024, Kilitch Drugs (India) Ltd's Gross Profit amounts to 557.8m INR.

What is Kilitch Drugs (India) Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
23%

Over the last year, the Gross Profit growth was -5%. The average annual Gross Profit growth rates for Kilitch Drugs (India) Ltd have been 21% over the past three years , 23% over the past five years .

Back to Top